Geode Capital Management’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.96M | Buy |
3,279,791
+4,523
| +0.1% | +$12.4K | ﹤0.01% | 2434 |
|
|
2025
Q1 | $5.5M | Buy |
3,275,268
+82,187
| +3% | +$138K | ﹤0.01% | 2611 |
|
|
2024
Q4 | $5.21M | Buy |
3,193,081
+26,601
| +0.8% | +$43.4K | ﹤0.01% | 2731 |
|
|
2024
Q3 | $13.2M | Buy |
3,166,480
+276,055
| +10% | +$1.15M | ﹤0.01% | 2212 |
|
|
2024
Q2 | $15.8M | Buy |
2,890,425
+473,907
| +20% | +$2.59M | ﹤0.01% | 2057 |
|
|
2024
Q1 | $24.2M | Buy |
2,416,518
+162,682
| +7% | +$1.63M | ﹤0.01% | 1805 |
|
|
2023
Q4 | $9.2M | Buy |
2,253,836
+206,248
| +10% | +$842K | ﹤0.01% | 2394 |
|
|
2023
Q3 | $7.93M | Buy |
2,047,588
+65,058
| +3% | +$252K | ﹤0.01% | 2401 |
|
|
2023
Q2 | $11.8M | Buy |
1,982,530
+201,565
| +11% | +$1.2M | ﹤0.01% | 2188 |
|
|
2023
Q1 | $5.82M | Sell |
1,780,965
-27,399
| -2% | -$89.6K | ﹤0.01% | 2569 |
|
|
2022
Q4 | $7.14M | Buy |
1,808,364
+109,863
| +6% | +$434K | ﹤0.01% | 2470 |
|
|
2022
Q3 | $10.2M | Buy |
1,698,501
+47,279
| +3% | +$284K | ﹤0.01% | 2241 |
|
|
2022
Q2 | $10.6M | Buy |
1,651,222
+124,511
| +8% | +$801K | ﹤0.01% | 2207 |
|
|
2022
Q1 | $12.6M | Sell |
1,526,711
-22,472
| -1% | -$186K | ﹤0.01% | 2192 |
|
|
2021
Q4 | $24M | Buy |
1,549,183
+7,551
| +0.5% | +$117K | ﹤0.01% | 1831 |
|
|
2021
Q3 | $34.7M | Buy |
1,541,632
+991,384
| +180% | +$22.3M | ﹤0.01% | 1584 |
|
|
2021
Q2 | $10.8M | Buy |
550,248
+137,811
| +33% | +$2.71M | ﹤0.01% | 2403 |
|
|
2021
Q1 | $13.8M | Buy |
+412,437
| New | +$13.8M | ﹤0.01% | 2121 |
|